Polynovo Ltd - Asset Resilience Ratio

Latest as of June 2025: 5.46%

Polynovo Ltd (PNV) has an Asset Resilience Ratio of 5.46% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Polynovo Ltd (PNV) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$6.96 Million
≈ $4.92 Million USD Cash + Short-term Investments

Total Assets

AU$127.41 Million
≈ $90.15 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Polynovo Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of Polynovo Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Polynovo Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Polynovo Ltd market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$6.91 Million 5.42%
Short-term Investments AU$50.00K 0.04%
Total Liquid Assets AU$6.96 Million 5.46%

Asset Resilience Insights

  • Limited Liquidity: Polynovo Ltd maintains only 5.46% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Polynovo Ltd Industry Peers by Asset Resilience Ratio

Compare Polynovo Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 36.63%
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
Medical Devices 2.82%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 9.52%
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
Medical Devices 14.72%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.47%
DRGEM Corporation
KQ:263690
Medical Devices 0.50%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.39%

Annual Asset Resilience Ratio for Polynovo Ltd (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Polynovo Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 5.46% AU$6.96 Million
≈ $4.92 Million
AU$127.41 Million
≈ $90.15 Million
-16.88pp
2024-06-30 22.34% AU$24.29 Million
≈ $17.19 Million
AU$108.72 Million
≈ $76.93 Million
+22.29pp
2023-06-30 0.05% AU$50.00K
≈ $35.38K
AU$92.62 Million
≈ $65.54 Million
-0.09pp
2022-06-30 0.14% AU$50.00K
≈ $35.38K
AU$34.97 Million
≈ $24.74 Million
+0.01pp
2021-06-30 0.13% AU$50.00K
≈ $35.38K
AU$38.34 Million
≈ $27.13 Million
0.00pp
2020-06-30 0.13% AU$50.00K
≈ $35.38K
AU$37.86 Million
≈ $26.79 Million
-0.05pp
2019-06-30 0.18% AU$50.00K
≈ $35.38K
AU$28.23 Million
≈ $19.97 Million
-63.70pp
2018-06-30 63.88% AU$19.05 Million
≈ $13.48 Million
AU$29.82 Million
≈ $21.10 Million
+63.46pp
2017-06-30 0.41% AU$50.00K
≈ $35.38K
AU$12.06 Million
≈ $8.53 Million
+0.10pp
2016-06-30 0.31% AU$50.00K
≈ $35.38K
AU$16.02 Million
≈ $11.34 Million
-0.43pp
2015-06-30 0.74% AU$60.00K
≈ $42.45K
AU$8.13 Million
≈ $5.75 Million
+0.10pp
2014-06-30 0.64% AU$60.00K
≈ $42.45K
AU$9.41 Million
≈ $6.66 Million
-12.82pp
2013-06-30 13.46% AU$1.16 Million
≈ $820.77K
AU$8.62 Million
≈ $6.10 Million
-7.42pp
2012-06-30 20.88% AU$1.86 Million
≈ $1.32 Million
AU$8.91 Million
≈ $6.30 Million
-11.06pp
2011-06-30 31.94% AU$3.76 Million
≈ $2.66 Million
AU$11.77 Million
≈ $8.33 Million
+31.54pp
2010-06-30 0.40% AU$60.00K
≈ $42.45K
AU$15.02 Million
≈ $10.63 Million
-86.21pp
2000-06-30 86.61% AU$10.36 Million
≈ $7.33 Million
AU$11.96 Million
≈ $8.46 Million
--
pp = percentage points

About Polynovo Ltd

AU:PNV Australia Medical Devices
Market Cap
$488.82 Million
AU$690.84 Million AUD
Market Cap Rank
#12647 Global
#321 in Australia
Share Price
AU$1.00
Change (1 day)
+0.50%
52-Week Range
AU$0.88 - AU$1.67
All Time High
AU$4.01
About

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more